Ongoing, global campaign targeting bilateral and multilateral donors to step up funding for viral hepatitis and harm reduction to curb the epidemics.
Despite HCV and harm reduction programs saving lives and costs, the funding necessary to apply these innovations to accelerate treatment and diagnosis is absent. More
“It’s been more than 5 years since we cured hepatitis C...where’s my package?”
Investing in HCV elimination requires national programs to provide services for key populations, particularly people who use and inject drugs who are disproportionately affected by the virus. More
PEPFAR Watch tracks the specific language in the Country Operational Plans, and activists prepare recommendations and demands to improve the policy guidance and inform service delivery. More
An open letter sent to Unitaid demands continuous investment towards HBV and HCV elimination, and to address the needs of 354 million people living with viral hepatitis worldwide. More